Patient safety - Mission for the future - Healthcare-associated infections and antibiotic resistances;Patientensicherheit -Auftrag für die Zukunft - Behandlungsassoziierte Infektionen und Antibiotikaresistenzen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 49, Issue 7-8, 2014, Pages 474-481

  Friedrich, Alex W ^a  

^a NONE

Author keywords

antibiotic resistance; clinical microbiology; HAI; healthcare associated infections; HRMO; hygienist; MRSA

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HEALTH CARE QUALITY; HEALTHCARE ASSOCIATED INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NONHUMAN; PATIENT CARE; PATIENT SAFETY; PREVALENCE; CROSS INFECTION; HUMAN; IATROGENIC DISEASE;

CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; IATROGENIC DISEASE; PATIENT SAFETY;

EID: 84906572536     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0034-1386710     Document Type: Article

References (22)

1. WHO. Social Development and Ageing: Crisis or opportunity. 2000. http://www.who.int/ageing/publications/development/alc-social-development.pdf
2. Entwicklung von sektorenübergreifenden Qualitätsindikatoren: Entscheidung des Gemeinsamen Bundesausschusses 20.10.2011.
3. Rahamat-Langendoen J. C. et al. Rapid detection of a norovirus pseudo-outbreak by using real-time sequence based information. J Clin Virol: 2013; 58 245 248
4. European Centre for Disease Prevention and Control (ECDC) Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Technical report ECDC, 2013. http://www.ecdc.europa.eu/en/publications
5. http://www.ecdc.eu
6. Umscheid C. A. et al. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol: 2011; 32 101 114
7. Marra A. R. et al. Preventing catheter-associated urinary tract infection in the zero-tolerance era. Am J Infect Control: 2011; 39 817 822
8. Filius P. M. et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother: 2005; 49 2879 2886 (Pubitemid 40917606)
9. Kollef M. H., Sherman G., Ward S., Fraser V. J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest: 1999; 115 462 474 (Pubitemid 29083057)
10. Köck R. et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19688
11. Köck R. et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS One: 2013; 8
12. Meyer E., Schröder C., Gastmeier P., Geffers C. The reduction of nosocomial MRSA infection in Germany - an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012. Dtsch Arztebl Int: 2014; 111 331 336
13. Jurke A. et al. Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveill http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20579: 2013; 18
14. ECDC http://www.ecdc.europa.eu/en/healthtopics/antimicrobial-resistance/ database/Pages/database.aspx
15. Glasner C. et al. European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group 2013. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries. Euro Surveill: 2013; 18
16. Bathoorn E. et al. Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013. Euro Surveill: 2013; 18
17. National Institute for Public Health and the Environment (RIVM) http://www.wip.nl
18. Empfehlungen zur Prävention und Kontrolle von MRSA in medizinischen Einrichtungen. Bundesgesundheitsblatt: 2014; 57 696 732
19. Köck R. et al. Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect: 2009; 71 320 326
20. http://www.bundesaerztekammer.de/page.asp?his=0.3
21. Friedrich A. W. et al. EUREGIO MRSA-net Twente/Münsterland -a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus. Euro Surveill: 2008; 13
22. Ciccolini M. et al. Infection prevention in a connected world: the case for a regional approach. Int J Med Microbiol: 2013; 303 380 387